Feasibility of dose-dense neoadjuvant chemotherapy followed by chemoradiotherapy in locally advanced cervical cancer: a real-world experience in the era of the interlace trial

被引:0
|
作者
Schivardi, Gabriella [1 ]
Caruso, Giuseppe [1 ]
Lapresa, Mariateresa [1 ]
Parma, Gabriella [1 ]
Lazzari, Roberta [2 ]
Vitis, Luigi De [1 ]
Stefani, Elena [1 ]
Achilarre, Maria Teresa [1 ]
Garbi, Annalisa [1 ]
Betella, Ilaria [1 ]
Aletti, Giovanni [1 ,3 ]
Maggioni, Angelo [1 ]
Zanagnolo, Vanna [1 ]
Colombo, Nicoletta [1 ,4 ]
Multinu, Francesco [1 ]
机构
[1] IEO European Inst Oncol IRCCS, Div Gynecol Oncol, Milan, Italy
[2] IEO European Inst Oncol IRCCS, Div Radiotherapy, Milan, Italy
[3] Univ Milan, Dept Oncol & Hemato Oncol, Milan, Italy
[4] Univ Milano Bicocca, Med Gynecol Oncol Unit, Milan, Italy
关键词
D O I
10.1136/ijgc-2024-IGCS.207
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EV088/#126
引用
收藏
页码:A127 / A128
页数:2
相关论文
共 50 条
  • [41] A randomized, phase III trial of induction chemotherapy followed by chemoradiation compared with chemoradiation alone in locally advanced cervical cancer: The GCIG INTERLACE Trial
    Ledermann, Jonathan
    McCormack, Mary
    Gallardo Rincon, Dolores
    Eminowicz, Gemma
    Diez, Patricia
    Farrelly, Laura
    Kent, Christopher
    Hudson, Emma
    Panades, Miguel
    Mathew, Tony
    Anand, Anjana
    Persic, Mojca
    Forrest, Jennifer
    Bhana, Rajanee
    Reed, Nick
    Drake, Anne
    Stobart, Hilary
    Mukhopadhyay, Asima
    Hacker, Anne-Marie
    Hackshaw, Allan
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S21 - S21
  • [42] Dose-Dense FEC Followed by Dose-Dense Ixabepilone as Neoadjuvant Treatment for Breast Cancer Patients: A Feasibility Study (vol 18, pg 924, 2013)
    Clavarezza, Matteo
    Bordonaro, Roberto
    Daniele, Bruno
    Ferrandina, Gabriella
    Barni, Sandro
    Turazza, Monica
    Coati, Francesca
    De Matteis, Andrea
    De Placido, Sabino
    Cognetti, Francesco
    Olmeo, Nina Antonina
    Carrozza, Francesco
    Bruzzi, Paolo
    Del Mastro, Lucia
    ONCOLOGIST, 2013, 18 (10): : 1149 - 1149
  • [43] Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer
    Li, Jing
    Li, Ya
    Wang, Huafeng
    Shen, Lifei
    Wang, Qun
    Shao, Siqi
    Shen, Yuhong
    Xu, Haoping
    Liu, Hua
    Cai, Rong
    Feng, Weiwei
    BMC CANCER, 2023, 23 (01)
  • [44] Oncologic outcomes of neoadjuvant chemotherapy followed by radical hysterectomy for locally advanced cervical cancer
    Rush, Margaret
    Nasioudis, Dimitrios
    Ko, Emily
    Haggerty, Ashley
    Cory, Lori
    Giuntoli, Robert
    Kim, Sarah
    Morgan, Mark
    Latif, Nawar
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S163 - S163
  • [45] Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer
    Jing Li
    Ya Li
    Huafeng Wang
    Lifei Shen
    Qun Wang
    Siqi Shao
    Yuhong Shen
    Haoping Xu
    Hua Liu
    Rong Cai
    Weiwei Feng
    BMC Cancer, 23
  • [46] Neoadjuvant chemotherapy followed by radiotherapy should not be a standard approach for locally advanced cervical cancer
    Shueng, PW
    Hsu, WL
    Jen, YM
    Wu, CJ
    Liu, HS
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 40 (04): : 889 - 896
  • [47] The role of neoadjuvant chemotherapy followed by radical surgery in the treatment of locally advanced cervical cancer
    Benedetti-Panici, PL
    Zullo, MA
    Muzii, L
    Manci, N
    Bellati, F
    Plotti, F
    Basile, S
    Angioli, R
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2003, 24 (06) : 467 - 470
  • [48] Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer
    Sugiyama, T
    Nishida, T
    Hasuo, Y
    Fujiyoshi, K
    Yakushiji, M
    GYNECOLOGIC ONCOLOGY, 1998, 69 (02) : 130 - 136
  • [49] TREATMENT OF LOCALLY ADVANCED CERVICAL CANCER (LACC) BY NEOADJUVANT CHEMOTHERAPY FOLLOWED BY ROBOTIC SURGERY
    Kurzeder, C.
    Harter, P.
    Prader, S.
    Heitz, F.
    Ataseven, B.
    Schneider, S.
    Traut, A.
    du Bois, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 909 - 909
  • [50] Neoadjuvant, biweekly, dose-dense chemotherapy with epirubicin and cyclophosphamide followed by docetaxel in primary breast cancer.
    Cramer, EM
    Moers, C
    Zarghooni, V
    Mallmann, P
    Warm, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 82S - 82S